- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Galectin Therapeutics Inc+ Add to Watchlist
GALT:US12.6470 USD 0.0670 0.53%
As of 10:47:20 ET on 07/11/2014.
Company Profile for Galectin Therapeutics Inc (GALT)
Galectin Therapeutics Inc. is a drug development company. The Company creates new therapies for fibrotic disease and cancer using its carbohydrate technology that targets galectin proteins which are key mediators of biologic and pathologic functions. Gelectin uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates.
Galectin Therapeutics Inc
Key Executives for Galectin Therapeutics Inc (GALT)
|James C CzirrChairman/Co-Founder||Peter G TraberPresident/CEO/Chief Medical Ofcr|
|Jack W CallicuttChief Financial Officer||Harold H ShlevinChief Operating Officer|
|Eliezer ZomerExec VP:Manufacturing||Sheila JayarajVP:Corp Strat & Investor Rltns|
|Rex HortonExecutive Director:Regulatory|